When BRAF p.V600E is present in tumor cells, as already described above, it usually promotes a modest proliferative cell capacity, probably explaining the better prognosis of patients, who experience an improved survival outcome with an indolent tumor course [35]. Here, BRAF is linked to neoplasm.